Mikhaylova Natalia Pavlovna

The MARTINEX scientific advisor, MD Ph.D., dermatovenerologist, cosmetologist, the associate professor of the Skin Diseases and Cosmetology Faculty in the Pirogov RNRMU Department of Additional Professional Education (DAPE), The president of the National Society of Mesotherapy (NSM) and of the Eurasian Association of Specialists in Injection Techniques (EASIT), a full member of the American Academy of Dermatology (AAD) and of the American Society for Laser Medicine and Surgery (ASLMS), a member of the expert council of the following companies: SINCLAIR PHARMA (UK), SuissElle (Switzerland), Energist (Great Britain), the director general of the Natalia Mikhailova International Academy of Aesthetic Medicine, the brand maker of the Dr. Mikhaylova MESALTERA professional cosmeceuticals and of the Dr. Mikhaylova Reform copyright clinics, the editor-in-Chief of the MedAesthetic-press publishing house (Les Nouvelles Esthétiques, Injection Cosmetology, Lasers & Aesthetics magazines) and the Reform magazine of Dr. Mikhaylova. An Officer of the Belgian Order of Merit in the Field of Inventions (2015), a winner of the Best Women of Russia Defenders of the Fatherland award in the nomination "For the Professional Honor, Dignity and Honorable Business Reputation" (2015) owing to her contribution to the development of aesthetic medicine, a winner of the UNESCO medal "For the contribution to the development of nanoscience and nanotechnology" (2016), a winner of the gold medal with distinction at the World Salon of Innovation, Scientific Research and New Technologies "Brussels-Innova/Eureka 2016" for the skin rejuvenation injectable preparation development, the title of the Best Cosmetologist in 2016 (the Komsomolskaya Pravda project), a winner of the Rospatent diploma in the nomination "100 best inventions of Russia — 2016" for the invention of the "Multicomponent mesothread containing hyaluronic acid, and for its manufacturing methods", which was recognized as the best of the 46206 applicants considered by the Rospatent Panel.

“Having lived through an extensive practical experience, we are striving to make the work of doctors more predictable and people's lives better. We are constantly in search of new methods and technologies enabling us to achieve the expected guaranteed effect and at the same time to avoid complications. We pursue our research not only in the field of solving aesthetic problems, but in medical technologies as well. We work out innovative nanomolecular formulations on the basis of our in-house developed and patented method of hyaluronic acid solid-phase modification; and we participate in federal nuclear medicine programs as developers of preparations for the radiation therapy of cancer diseases. In addition to developing preparations, we create and constantly improve methods that open up new opportunities for their use. High appreciation and international recognition allow us to understand that we have chosen the right direction and we are taking necessary and significant steps both for medicine in general and for each person individually."